Skip to main content
. Author manuscript; available in PMC: 2011 Jan 11.
Published in final edited form as: Mol Genet Metab. 2010 Sep 17;102(1):6–12. doi: 10.1016/j.ymgme.2010.09.004

Fig. 4.

Fig. 4

Relationship between oral doses of PYR and the resulting plasma levels of the drug. The daily doses of PYR, followed by the week(s) on that dose, are plotted against the resulting plasma levels (mg/L) for; (A) the Toronto patients, and (B) the New York patients.